Cargando…
Prevalence, predictors, and clinical relevance of α‐gal sensitization in patients with chronic urticaria
BACKGROUND: Little is known about α‐gal (galactose‐α‐1,3‐galactose) sensitization in patients with chronic urticaria (CU). The aim of this study was to examine the prevalence, predictors and clinical relevance of α‐gal sensitization in patients with CU. METHODS: Two consecutive cohorts of newly refe...
Autores principales: | Pedersen, Helena Swee‐Lin Trige, Sørensen, Jennifer Astrup, Madsen, Flemming, Linneberg, Allan, Leth‐Møller, Katja Biering, Vestergaard, Christian, Thomsen, Simon Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594966/ https://www.ncbi.nlm.nih.gov/pubmed/36286530 http://dx.doi.org/10.1002/clt2.12199 |
Ejemplares similares
-
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023) -
Occurrence and risk factors of mental disorders in patients with chronic urticaria
por: Ghazanfar, Misbah Noshela, et al.
Publicado: (2023) -
The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022) -
Symptoms and biomarkers associated with undiagnosed celiac seropositivity
por: Kårhus, Line Lund, et al.
Publicado: (2021) -
Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study
por: Ghazanfar, Misbah Noshela, et al.
Publicado: (2020)